Energy News / Shareholders Foundation, Inc.

NYSE:AMRX Shareholder Notice: Investigation over Possible Securities Laws Violations by Amneal Pharmaceuticals, Inc.

Via: ReleaseWire

Updated 8:00 AM CDT, Tue, June 25,2019

An investigation for investors in Amneal Pharmaceuticals, Inc. (NYSE: AMRX) shares over potential securities laws violations by Amneal Pharmaceuticals, Inc. was announced.

San Diego, CA -- (SBWIRE) -- 06/25/2019 -- An investigation was announced concerning potential securities laws violations by Amneal Pharmaceuticals, Inc., formerly Impax Laboratories Inc, in connection with certain financial statements.

Investors who purchased shares of Amneal Pharmaceuticals, Inc. (NYSE: AMRX), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether a series of statements by Amneal Pharmaceuticals, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Bridgewater, NJ based Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. Amneal Pharmaceuticals, Inc. reported that its annual Total Revenue rose from over $1.03 billion in 2017 to over $1.66 billion in 2018 and that its Net Income of $167.64 million in 2017 turned to a Net Loss of $169.72 million in 2018.

Recently the Company was among those sued in a wide-ranging lawsuit brought by 44 state attorneys general alleging an illegal conspiracy to inflate prices of more than 100 generic drugs, sometimes by more than 1,000%, and stifle competition.

Shares of Amneal Pharmaceuticals, Inc. (NYSE: AMRX) declined from $24.30 per share in September 2018 to as low as $6.77 per share on June 17, 2019.

Those who purchased shares of Amneal Pharmaceuticals, Inc. (NYSE: AMRX) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in conftact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

For more information on this press release visit:
http://www.sbwire.com/press-releases/nyseamrx-shareholder-notice-investigation-over-possible-securities-laws-violations-by-amneal-pharmaceuticals-inc-1236879.htm

Media Relations Contact
Michael Daniels
1-858-779-1554
Email: Click to Email Michael Daniels
Web: http://www.ShareholdersFoundation.com